Applicant, as named in the Orange Book

Dow Pharm

Next listed expiry: Altreno on 22 Aug 2038. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Altreno NDA 209353 tretinoin	tretinoin	22 Aug 2038 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Atralin NDA 022070 tretinoin	tretinoin	open now no listed protection	no listed protection